Package 65219-594-20

Brand: tyenne

Generic: tocilizumab-aazg
NDC Package

Package Facts

Identity

Package NDC 65219-594-20
Digits Only 6521959420
Product NDC 65219-594
Product ID 65219-594_c6e5034e-6d33-4c6f-bb0e-d03bea292c3a
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (65219-594-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-04-15
Brand tyenne
Generic tocilizumab-aazg
Sample Package No

Linked Drug Pages (1)

TYENNE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "c6e5034e-6d33-4c6f-bb0e-d03bea292c3a", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["I031V2H011"], "rxcui": ["2679431", "2679438", "2679440", "2679441", "2679442", "2679443"], "spl_set_id": ["e400bbe6-43c5-4de6-82b9-cb44ce3cd906"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (65219-594-20)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "65219-594-20", "marketing_start_date": "20240415"}], "brand_name": "TYENNE", "product_id": "65219-594_c6e5034e-6d33-4c6f-bb0e-d03bea292c3a", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "65219-594", "generic_name": "Tocilizumab-aazg", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TYENNE", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "400 mg/20mL"}], "application_number": "BLA761275", "marketing_category": "BLA", "marketing_start_date": "20240415", "listing_expiration_date": "20261231"}